0001213900-20-022897.txt : 20200819 0001213900-20-022897.hdr.sgml : 20200819 20200819162900 ACCESSION NUMBER: 0001213900-20-022897 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 EFFECTIVENESS DATE: 20200819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373611 FILM NUMBER: 201117373 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001733413 TFF Pharmaceuticals, Inc. 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 737-802-1979 DELAWARE None None Corporation true 2018 ROBERT S. MILLS, JR. 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director BRIAN WINDSOR 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Executive Officer Director KIRK COLEMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Executive Officer AARON FLETCHER 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director GLENN MATTES 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Executive Officer Director STEPHEN ROCAMBOLI 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director HARLAN WEISMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director RANDY THURMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director MALCOLM FAIRBAIRN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director Pharmaceuticals Decline to Disclose 06b false 2020-08-10 false true false 0 Jefferies LLC 2347 None None 520 MADISON AVENUE NEW YORK NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT NY NEW YORK NC NORTH CAROLINA TX TEXAS WA WASHINGTON false 25913560 25913560 0 false 23 1554814 0 0 false TFF Pharmaceuticals, Inc. /s/ KIRK COLEMAN KIRK COLEMAN CHIEF FINANCIAL OFFICER 2020-08-14